10 Pfizer government affairs leaders
Half of these Pfizer government affairs leaders work on U.S. policy, from the senior vice president to federal and state relations directors, and half on international work covering commercial policy, the EU, global trade, Malaysia through Pakistan, and Sweden. Roles in the U.S. House of Representatives, the U.S. Department of Energy and Sveriges riksdag also appear, useful context ahead of Medicare reimbursement, trade or EU policy debates.
Professionals to explore
Abram Bieliauskas
LinkedInExperience: Director, U.S. Federal Policy · Pfizer
$539 per 30-minute call
Medicare Part B, 340B and IRA policy are the areas Abram Bieliauskas names as Director, U.S. Federal Policy at Pfizer (since 2025), managing a health care coverage and access policy portfolio. Earlier titles include Senior Manager, U.S. Federal Policy at Pfizer (2022-2025), Associate Director, Government Affairs (2019-2021) and Manager, Government Affairs (2017-2019) at The ALS Association, and Specialist, Government Affairs & Advocacy at Pancreatic Cancer Action Network (2016-2017). Abram fits questions on Medicare reimbursement and 340B policy.
Is this you? Claim your profile and get paid for calls.
Amy Christian
LinkedInExperience: Director, State Government Relations- Florida, Mississippi, Louisiana, Arkansas · Pfizer
$404 per 30-minute call
Amy Christian has been Director, State Government Relations- Florida, Mississippi, Louisiana, Arkansas at Pfizer since 2022, and was Senior Manager, State Government Relations- Florida (2021-2023). Earlier titles include Alliance Development Manager at Pfizer (2015-2021) and Director, Government Relations at Johnson & Blanton (2006-2015). Amy is the one state government relations lead in the group, a fit for questions on state legislatures in Florida and the other states in that title.
Is this you? Claim your profile and get paid for calls.
Andrea Chiarello
LinkedInExperience: Former Director - Head of EU Government Affairs · Pfizer
$539 per 30-minute call
Based in Brussels, Andrea Chiarello leads Pfizer's policy, public affairs and communications strategy towards EU policy-makers and key stakeholders such as patient advocacy groups as Head of EU Policy & Communications (since 2025), and their LinkedIn profile also names an AmCham EU Board Member role. Earlier Pfizer titles include Director - Head of EU Government Affairs (2020-2025), Senior Manager - EU Government Affairs (2019-2020) and Manager - EU Government Affairs (2017-2019). Andrea fits questions on EU pharmaceutical legislation.
Is this you? Claim your profile and get paid for calls.
Catherine Robinson
LinkedInExperience: Senior Director, Global Trade Policy and Int l Govt Affairs, · Pfizer
$673 per 30-minute call
Catherine Robinson holds two current Pfizer titles, Head, Global Access Initiatives & Accord for a Healthier World, Int'l Policy & Communications (IPC) (since 2025) and Senior Director, Global Trade Policy and Int l Govt Affairs (since 2023). Earlier titles include Director, International Government Affairs and Global Trade Policy at Pfizer (2016-2023) and Director, Global Government Affairs at Amgen (2011-2016). Catherine fits questions on trade policy and global access programs for medicines.
Is this you? Claim your profile and get paid for calls.
Francisco Carrillo
LinkedInExperience: Senior Director, Federal Government Relations · Pfizer
$673 per 30-minute call
Francisco Carrillo's federal agency roles include Deputy Assistant Secretary for Intergovernmental & External Affairs at U.S. Department of Energy (DOE) (2015-2017) and Deputy Director of Intergovernmental Affairs and Director of Latino Affairs at U.S. Department of the Interior (2012-2015), and since 2021 Francisco has been Senior Director, Federal Government Relations at Pfizer. Francisco was also Executive Director of Federal Relations at UCLA (2017). Francisco fits questions on working with federal agencies.
Is this you? Claim your profile and get paid for calls.
Jennifer Walton
LinkedInExperience: Senior Vice President, U.S. Policy & Government Relations · Pfizer
$2,019 per 30-minute call
Jennifer Walton has been Senior Vice President, U.S. Policy & Government Relations at Pfizer since 2021, and earlier held Vice President, Federal Government Relations (2017-2020) and Senior Director, Federal Government Relations (2010-2017) at Pfizer. Before Pfizer, Jennifer was Senior Director, Federal Government Relations at PhRMA (2009-2010) and Deputy Legislative Director for U.S. Senator Pat Roberts (2001-2008). Jennifer fits questions on how Pfizer's U.S. policy and federal relations work is organized.
Is this you? Claim your profile and get paid for calls.
Jennifer Young
LinkedInExperience: Vice President & Head, International Commercial Policy and Communications · Pfizer
$1,211 per 30-minute call
Jennifer Young leads Pfizer's International Commercial Policy and Communications team as Vice President & Head (since 2025), overseeing development and execution of public policy and government affairs. Earlier Pfizer titles include Vice President & Head, Global Business Policy and Public Affairs (2024-2025), Vice President, Global Policy and Public Affairs - Specialty Care (2022-2023) and Senior Director and Lead, Policy and Public Affairs - Emerging Asia (2021-2022). Jennifer fits questions on commercial policy outside the U.S.
Is this you? Claim your profile and get paid for calls.
Matthew Stroia
LinkedInExperience: Senior Director, Federal Government Relations · Pfizer
$673 per 30-minute call
Senior Director, Federal Government Relations at Pfizer since 2021, Matthew Stroia was Chief of Staff in the U.S. House of Representatives (2012-2021), and Legislative Director (2011-2012) and Legislative Counsel (2008-2011) there. Earlier, Matthew was Legal Clerk at Department of the Navy, Office of the General Counsel (2005-2006). Matthew fits questions on how House offices weigh pharmaceutical policy asks.
Is this you? Claim your profile and get paid for calls.
Pia Steensland
LinkedInExperience: Director, Policy & Public Affairs, Pfizer Sweden · Pfizer
$471 per 30-minute call
A former Member of the Parliament Christian Democrats at Sveriges riksdag (2018-2022), Pia Steensland has been Director, Policy & Public Affairs, Pfizer Sweden since 2023. Pia's Karolinska Institutet titles included Independent Research Group Leader (2015-2018), Senior Researcher (2014-2018) and Associate Professor (Docent) in Neuropharmacology (2011-2018), and Pia holds a PhD. Pia fits questions on Swedish health policy and on moving from a legislature into pharmaceutical policy work.
Is this you? Claim your profile and get paid for calls.
Shamie Zainal
LinkedInExperience: Director, Global Policy and Public Affairs, Malaysia Indonesia Singapore Philippine Pakistan Lead · Pfizer
$471 per 30-minute call
Shamie Zainal, based in Kuala Lumpur, is Director, Global Policy and Public Affairs, Malaysia Indonesia Singapore Philippine Pakistan Lead at Pfizer (since 2024) and was Director, Global EM Policy and Public Affairs (2019-2024). At Novartis Malaysia, Shamie's titles included Head of Oncology Policy and Market Access (2015-2019) and National Key Account Manager (2011-2012). Shamie fits questions on policy and market access in Malaysia, Indonesia, Singapore, the Philippines and Pakistan.
Is this you? Claim your profile and get paid for calls.
Choose the right perspective
For U.S. federal questions, Jennifer Walton, Matthew Stroia, Francisco Carrillo and Abram Bieliauskas are the fit, with Amy Christian for state legislatures. International questions go to Jennifer Young for commercial policy, Catherine Robinson for trade, Andrea Chiarello for the EU, Shamie Zainal for Malaysia through Pakistan and Pia Steensland for Sweden.
Questions to take into the conversation
- 01How does Pfizer coordinate federal and state government relations when the same policy moves at both levels?
- 02How do Medicare drug pricing provisions change what a pharmaceutical company asks of Congress?
- 03How does Pfizer's EU policy team work with country teams such as Pfizer Sweden on a new EU proposal?
About this directory
This is a professional research starting point based on business profile data retrieved on . Titles and companies reflect that source snapshot; roles marked former had ended by then. Check the linked profiles for current details. Inclusion does not imply Instant Expert membership or availability.